Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06772181 · ClinicalTrials.gov registry record · NA

A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation

A NA study of Breast Carcinoma, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06772181 is a NA study of Breast Carcinoma that is actively recruiting participants, run by University of Washington. The registered enrollment target is 40 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06772181, a NA study of Breast Carcinoma, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

This clinical trial evaluates a digital health intervention for improving symptoms and physical activity among patients with breast cancer undergoing radiation. Cancer-related fatigue is common and strongly associated with quality of life during and after treatment. Increasing emphasis on early symptom detection and management has prompted initiatives to collect patient-reported fatigue from all patients during treatment. Mind-body interventions including physical activity and yoga are recommendations to treat fatigue and comorbid (coexisting) symptoms. Lower socioeconomic status has not only been associated with higher rates of physical inactivity but also with perceptions that it could negatively impact fatigue and quality of life during treatment. A virtual mind-body program called Integrative Medicine at Home (IM@Home) includes cardio fitness and yoga classes in a bundled intervention that has demonstrated decreased fatigue, depression, insomnia, and symptom distress among patients undergoing breast radiation. The IM@Home program may also increase physical activity among patients with breast cancer undergoing radiation.

Conditions Studied

Breast Carcinoma

Interventions

  • OTHER Questionnaire Administration
  • OTHER Medical Device Usage and Evaluation
  • OTHER Interview
  • BEHAVIORAL IM@Home Program

Study Locations (2)

Washington

  • Fred Hutch/University of Washington Cancer Consortium - Seattle
  • MultiCare Valley Hospital (Spokane) - Spokane Valley

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-03-04
Est. Completion 2026-09-30
Phase NA

Sponsor

University of Washington

1,048 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06772181

The ClinicalTrials.gov registry entry for NCT06772181 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (95% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT06772181 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT06772181 about?

NCT06772181 is a clinical study titled "A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation". This clinical trial evaluates a digital health intervention for improving symptoms and physical activity among patients with breast cancer undergoing radiation. Cancer-related fatigue is common and strongly associated with quality of life during and after treatment. Increasing emphasis on early symp...

What is the current status of trial NCT06772181?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-03-04. Estimated completion is 2026-09-30.

What conditions does trial NCT06772181 study?

This clinical trial studies the following conditions: Breast Carcinoma.

What interventions are being tested in trial NCT06772181?

The interventions under investigation include: Questionnaire Administration (OTHER), Medical Device Usage and Evaluation (OTHER), Interview (OTHER), IM@Home Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06772181?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06772181 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Carcinoma

All registered trials for this condition

Washington

All trials with a study site in Washington

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.